While PSMD3 regulated nuclear factor-kappa B (NF-κB) transcriptional activity in CML, we did not observe similar effects in FLT3+ AML cells. The gene discussed is FLT3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.